Drawing for WOMEN LEADERS IN ONCOLOGY

USPTO serial 87652646

WOMEN LEADERS IN ONCOLOGY

Reviewed by CopyMark Law Group

Reg. 5506735Status 710
Filing date
Status date
Registration date
Jul 3, 2018
Examiner
SPARER, KATERINA DOROTHY
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with WOMEN LEADERS IN ONCOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew J. Gryzlo

MATTHEW J. GRYZLO MCDERMOTT WILL & EMERY LLP444 W LAKE ST STE 4000CHICAGO, IL 60606-0029UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business and professional networking services, namely, creating research, business, and philanthropy connections in the field of oncology drug development, clinical research, and clinical practice; organization and implementation of professional networking opportunities in the nature of arranging and conducting professional business conferences and exhibitions and networking events in the fields of oncology drug development, clinical research, and clinical practice for business networking purposes; Business collaboration services, namely, promoting collaboration between current and rising women leaders in the field of oncology to achieve advances in the field of cancer research and treatmentSECTION 8 - CANCELLEDMar 15, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 17, 2025C8..CANCELLED SEC. 8 (6-YR)—
Jul 3, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 3, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 17, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 17, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 28, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 14, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 13, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 13, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 9, 2018ALIEASSIGNED TO LIE—
Feb 26, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 5, 2018GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 5, 2018GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Feb 5, 2018CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Jan 29, 2018DOCKASSIGNED TO EXAMINER—
Oct 31, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 30, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 23, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance